Literature DB >> 10584437

Current imaging modalities for the diagnosis of breast cancer.

S L Edell1, M D Eisen.   

Abstract

Although mammography still remains the gold standard for breast cancer screening and diagnosis, it typically cannot differentiate benign from malignant disease and is less accurate in patients with dense glandular breasts. This article is an overview of imaging modalities that have emerged to augment mammography and improve the accuracy of non-invasive breast cancer diagnosis. Ultrasound is currently used to differentiate breast masses and guide aspirations and biopsies. Magnetic resonance imaging has excellent sensitivity in demonstrating breast cancer but a low specificity. Nuclear medicine studies have recently emerged that detect the increased metabolic rate and vascularity of breast cancers. Other modalities, such as thermography and computed tomography, have a more limited utility for breast cancer diagnosis. Digital mammography is among other emerging technological advancements that will continue to develop and improve the accuracy of breast cancer diagnosis in the future.

Entities:  

Mesh:

Year:  1999        PMID: 10584437

Source DB:  PubMed          Journal:  Del Med J        ISSN: 0011-7781


  3 in total

1.  Exhaled breath temperature in NSCLC: could be a new non-invasive marker?

Authors:  Giovanna E Carpagnano; Donato Lacedonia; Antonio Spanevello; Domenico Martinelli; Valerio Saliani; Cinzia Ruggieri; Maria P Foschino-Barbaro
Journal:  Med Oncol       Date:  2014-04-11       Impact factor: 3.064

2.  Finite element modelling and validation for breast cancer detection using digital image elasto-tomography.

Authors:  Hina M Ismail; Chris G Pretty; Matthew K Signal; Marcus Haggers; J Geoffrey Chase
Journal:  Med Biol Eng Comput       Date:  2018-03-10       Impact factor: 2.602

3.  Temperature differences are associated with malignancy on lung lesions: a clinical study.

Authors:  Christodoulos Stefanadis; Christina Chrysohoou; Demosthenes B Panagiotakos; Elisabeth Passalidou; Vasiliki Katsi; Vlassios Polychronopoulos; Pavlos K Toutouzas
Journal:  BMC Cancer       Date:  2003-01-06       Impact factor: 4.430

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.